LEADER 02057oam  2200493   450 
001 9910703514803321
005 20150604134153.0
035   $a(CKB)5470000002432557
035   $a(OCoLC)904255148
035   $a(EXLCZ)995470000002432557
100   $a20150302d2015      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 12$aA continuing investigation into the fungal meningitis outbreak and whether it could have been prevented $ehearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 16, 2013
210  1$aWashington :$cU.S. Government Printing Office,$d2015.
215   $a1 online resource (v, 134 pages)
300   $aTitle from title screen (viewed on Mar. 2, 2015).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
300   $a"Serial No. 113-31."
320   $aIncludes bibliographical references.
517   $aContinuing investigation into the fungal meningitis outbreak and whether it could have been prevented 
606   $aMeningitis$zUnited States$xPrevention
606   $aDrugs$xDosage forms$xHealth aspects$zUnited States
606   $aDrug factories$xInspection$zUnited States
606   $aPharmaceutical industry$xGovernment policy$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aMeningitis$xPrevention.
615  0$aDrugs$xDosage forms$xHealth aspects
615  0$aDrug factories$xInspection
615  0$aPharmaceutical industry$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bSTF
801  2$bCOO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910703514803321
996   $aA continuing investigation into the fungal meningitis outbreak and whether it could have been prevented$93476677
997   $aUNINA